Nucleic Acid Amplification Testing Market Size, Share, Trends, Growth Outlook

Nucleic Acid Amplification Testing Market is estimated to increase at a growth rate of 10.5% CAGR over the forecast period from 2024 to 2030.

The global Nucleic Acid Amplification Testing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Polymerase Chain Reaction (PCR) tests, Isothermal Nucleic Acid Amplification Technology (INAAT) tests, Ligase Chain Reaction (LCR) tests), By Application (Infectious disease testing , Oncology testing, Genetic & mitochondrial disease testing, Others), By End-user (Hospitals, Central and reference laboratories, Others).

An introduction to Nucleic Acid Amplification Testing Market in 2024

In 2024, the nucleic acid amplification testing (NAAT) market is witnessing significant expansion driven by the demand for accurate, rapid, and sensitive diagnostic techniques for infectious diseases, including COVID-19, sexually transmitted infections, and viral hepatitis. NAAT techniques such as PCR, RT-PCR, and LAMP offer high specificity and sensitivity, enabling early detection and effective disease management. With the ongoing threat of infectious diseases and the emphasis on molecular diagnostics, the NAAT market is experiencing rapid innovation, adoption, and integration into healthcare systems globally.

Nucleic Acid Amplification Testing Market Trend: Adoption of Point-of-Care Nucleic Acid Amplification Testing

A prominent trend in the Nucleic Acid Amplification Testing Market is the increasing adoption of point-of-care (POC) nucleic acid amplification testing (NAAT). As the demand for rapid and accurate molecular diagnostics continues to rise, there's a growing preference for POC NAAT platforms that offer on-site testing capabilities, fast turnaround times, and decentralized testing options. POC NAAT devices enable timely diagnosis and management of infectious diseases such as COVID-19, influenza, and sexually transmitted infections, thereby enhancing patient care, infection control, and public health surveillance. This trend towards POC NAAT drives the market towards more accessible and convenient molecular testing solutions.

Nucleic Acid Amplification Testing Market Driver: Rising Incidence of Infectious Diseases and Genetic Disorders

A significant driver propelling the Nucleic Acid Amplification Testing Market is the rising incidence of infectious diseases and genetic disorders worldwide. Infectious diseases such as HIV, hepatitis, tuberculosis, and respiratory viruses pose significant health threats, necessitating accurate and timely diagnosis for effective disease management and control. Additionally, the increasing recognition of genetic factors in disease susceptibility, drug response, and personalized medicine drives the demand for molecular diagnostics to detect genetic mutations, variants, and gene expression patterns. The growing burden of infectious diseases and genetic disorders fuels the demand for nucleic acid amplification testing platforms and drives market growth.

Market Opportunity Development of Multiplex NAAT Assays

An enticing opportunity within the Nucleic Acid Amplification Testing Market lies in the development of multiplex nucleic acid amplification assays capable of detecting multiple targets simultaneously. Multiplex NAAT assays enable the simultaneous detection and identification of multiple pathogens or genetic markers in a single test, offering advantages such as increased throughput, reduced sample volume, and cost-effective testing. These assays have applications in syndromic testing, outbreak surveillance, and comprehensive molecular profiling, thereby addressing the need for efficient diagnostics in various clinical and research settings. By investing in the development of multiplex NAAT assays and platforms, companies can meet the growing demand for comprehensive molecular testing solutions, expand their product offerings, and capitalize on new opportunities in the market.

Nucleic Acid Amplification Testing Market Market Segmentation

By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Nucleic Acid Amplification Testing Market Companies

Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
Danaher Corp
F. Hoffmann-La Roche Ltd
Illumina Inc
Novartis AG
Seegene Inc
Siemens Healthineers

Reasons to Buy the Nucleic Acid Amplification Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Nucleic Acid Amplification Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Nucleic Acid Amplification Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Nucleic Acid Amplification Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Nucleic Acid Amplification Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Nucleic Acid Amplification Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Nucleic Acid Amplification Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Nucleic Acid Amplification Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Nucleic Acid Amplification Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Nucleic Acid Amplification Testing Industry
4.2 Key Market Trends in Nucleic Acid Amplification Testing Industry
4.3 Potential Opportunities in Nucleic Acid Amplification Testing Industry
4.4 Key Challenges in Nucleic Acid Amplification Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Nucleic Acid Amplification Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Nucleic Acid Amplification Testing Market Outlook by Segments
7.1 Nucleic Acid Amplification Testing Market Outlook by Segments, $ Million, 2021- 2030
By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others

8 North America Nucleic Acid Amplification Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Nucleic Acid Amplification Testing Markets in 2024
8.2 North America Nucleic Acid Amplification Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Nucleic Acid Amplification Testing Market size Outlook by Segments, 2021-2030
By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others

9 Europe Nucleic Acid Amplification Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Nucleic Acid Amplification Testing Markets in 2024
9.2 Europe Nucleic Acid Amplification Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Nucleic Acid Amplification Testing Market Size Outlook by Segments, 2021-2030
By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others

10 Asia Pacific Nucleic Acid Amplification Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Nucleic Acid Amplification Testing Markets in 2024
10.2 Asia Pacific Nucleic Acid Amplification Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Nucleic Acid Amplification Testing Market size Outlook by Segments, 2021-2030
By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others

11 South America Nucleic Acid Amplification Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Nucleic Acid Amplification Testing Markets in 2024
11.2 South America Nucleic Acid Amplification Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Nucleic Acid Amplification Testing Market size Outlook by Segments, 2021-2030
By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others

12 Middle East and Africa Nucleic Acid Amplification Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Nucleic Acid Amplification Testing Markets in 2024
12.2 Middle East and Africa Nucleic Acid Amplification Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Nucleic Acid Amplification Testing Market size Outlook by Segments, 2021-2030
By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Becton, Dickinson and Company
bioMérieux SA
Bio-Rad Laboratories Inc
Danaher Corp
F. Hoffmann-La Roche Ltd
Illumina Inc
Novartis AG
Seegene Inc
Siemens Healthineers
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Polymerase Chain Reaction (PCR) tests
Isothermal Nucleic Acid Amplification Technology (INAAT) tests
Ligase Chain Reaction (LCR) tests
By Application
Infectious disease testing
-COVID-19 testing
-Mosquito borne disease testing
-Influenza testing
-Sexually transmitted infections testing
-Hepatitis testing
-Tuberculosis testing
-Others
Oncology testing
Genetic & mitochondrial disease testing
Others
By End-user
Hospitals
Central and reference laboratories
Others